153 related articles for article (PubMed ID: 27476072)
1. The effect of glycaemic control in type 2 diabetic patients with subclinical hypothyroidism.
Fu X; Xia H; Mao H; Zhao S; Wang Z
J Endocrinol Invest; 2016 Dec; 39(12):1453-1458. PubMed ID: 27476072
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
[TBL] [Abstract][Full Text] [Related]
3. Subclinical hypothyroidism increases insulin resistance in normoglycemic people.
Yang W; Jin C; Wang H; Lai Y; Li J; Shan Z
Front Endocrinol (Lausanne); 2023; 14():1106968. PubMed ID: 37484968
[TBL] [Abstract][Full Text] [Related]
4. Subclinical hypothyroidism contributes to poor glycemic control in patients with type 2 diabetes mellitus, and ellagic acid attenuates methimazole-induced abnormal glucose metabolism in mice model.
Liu Y; Li X; Zhu Y; Liu J; Liu S
J Food Biochem; 2021 Jun; 45(6):e13753. PubMed ID: 33955004
[TBL] [Abstract][Full Text] [Related]
5. Subclinical hypothyroidism may be associated with elevated high-sensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia.
Tuzcu A; Bahceci M; Gokalp D; Tuzun Y; Gunes K
Endocr J; 2005 Feb; 52(1):89-94. PubMed ID: 15758563
[TBL] [Abstract][Full Text] [Related]
6. Subclinical hypothyroidism is associated with early insulin resistance in Kuwaiti women.
Al Sayed A; Al Ali N; Bo Abbas Y; Alfadhli E
Endocr J; 2006 Oct; 53(5):653-7. PubMed ID: 16902262
[TBL] [Abstract][Full Text] [Related]
7. Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice.
Xiong WT; Gu L; Wang C; Sun HX; Liu X
J Ethnopharmacol; 2013 Dec; 150(3):935-45. PubMed ID: 24095831
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance in non-diabetic hypothyroid patients: a critical examination of METS-IR as a diagnostic marker.
Tunç Karaman S
Curr Med Res Opin; 2023 Nov; 39(11):1431-1437. PubMed ID: 37831409
[TBL] [Abstract][Full Text] [Related]
9. Poor glycemic control is associated with the risk of subclinical hypothyroidism in patients with type 2 diabetes mellitus.
Cho JH; Kim HJ; Lee JH; Park IR; Moon JS; Yoon JS; Lee IK; Won KC; Lee HW
Korean J Intern Med; 2016 Jul; 31(4):703-11. PubMed ID: 27271351
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.
Derosa G; Cicero AF; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Ferrari I; Gravina A; Fogari R
Hypertens Res; 2006 Nov; 29(11):849-56. PubMed ID: 17345784
[TBL] [Abstract][Full Text] [Related]
11. [Effect of panax quinquefolius saponin on insulin sensitivity in patients of coronary heart disease with blood glucose abnormality].
Zhang Y; Lu S; Liu YY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Dec; 27(12):1066-9. PubMed ID: 18198636
[TBL] [Abstract][Full Text] [Related]
12. [Primary preventive effect of metformin upon atherosclerosis in patients with type 2 diabetes mellitus].
Zhang XY; Du JL; Jia YJ; Bai R; Yang Y; Ba Y; Xing Q; Men LL
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2134-7. PubMed ID: 20058619
[TBL] [Abstract][Full Text] [Related]
13. Atherogenic Lipoproteins in Subclinical Hypothyroidism and Their Relationship with Hepatic Lipase Activity: Response to Replacement Treatment with Levothyroxine.
Brenta G; Berg G; Miksztowicz V; Lopez G; Lucero D; Faingold C; Murakami M; Machima T; Nakajima K; Schreier L
Thyroid; 2016 Mar; 26(3):365-72. PubMed ID: 26839156
[TBL] [Abstract][Full Text] [Related]
14. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
15. Dyslipidaemia and hypertension in patients with subclinical hypothyroidism.
Velkoska Nakova V; Krstevska B; Bosevski M; Dimitrovski Ch; Serafimoski V
Prilozi; 2009 Dec; 30(2):93-102. PubMed ID: 20087252
[TBL] [Abstract][Full Text] [Related]
16. Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism.
Pei YJ; Wang AM; Zhao Y; Yan L; Li M; White RE; Han GC
Gynecol Endocrinol; 2014 Aug; 30(8):553-6. PubMed ID: 24884959
[TBL] [Abstract][Full Text] [Related]
17. [Blood lipid, glucose and uric acid in people with subclinical hypothyroidism].
Liang LB; Zhang M; Huang HJ; Wang YJ; Li SQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 44(6):954-6. PubMed ID: 24490510
[TBL] [Abstract][Full Text] [Related]
18. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
[TBL] [Abstract][Full Text] [Related]
19. Evaluation response and effectiveness of thyroid hormone replacement treatment on lipid profile and function in elderly patients with subclinical hypothyroidism.
Arinzon Z; Zuta A; Peisakh A; Feldman J; Berner Y
Arch Gerontol Geriatr; 2007; 44(1):13-9. PubMed ID: 16621071
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of subclinical atherosclerosis in Chinese patients with newly diagnosed type 2 diabetes: a cross-sectional study.
Zheng TP; Liu YH; Yang LX; Qin SH; Liu HB
Atherosclerosis; 2015 Oct; 242(2):580-8. PubMed ID: 26318108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
